
Jennifer Mendoza
Research expert covering health, pharma and medtech

Detailed statistics
Share of cancer deaths attributable to select risk factors in the U.S. in 2019

Detailed statistics
Opinion on the efficacy of HPV vaccine in the U.S. 2022-2023

Detailed statistics
Opinion on the safety of HPV vaccine in the U.S. 2022-2023

Share of total cancer cases in the U.S. attributable to select risk factors in 2019
Proportion of total cancer cases in the United States attributable to select risk factors in 2019

Number of cancer cases among U.S. adults attributable to select risk factors in 2019
Number of cancer cases among adults in the United States attributable to select risk factors in 2019

Share of cancer deaths attributable to select risk factors in the U.S. in 2019
Proportion of cancer deaths in the United States attributable to select risk factors in 2019

Opinion on the efficacy of HPV vaccine in the U.S. 2022-2023
Distribution of opinion on the efficacy of Human papillomavirus (HPV) vaccine in the U.S. in 2022 and 2023

Opinion on the safety of HPV vaccine in the U.S. 2022-2023
Distribution of opinion on the safety of Human papillomavirus (HPV) vaccine in the U.S. in 2022 and 2023

Percentage of select cancers that were caused by HPV in the U.S. 2017-2021, by site
Percentage of select cancers that were probably caused by HPV in the U.S. per year from 2017 to 2021, by site

Number of cancer cases that were caused by HPV in the U.S. 2017-2021, by site
Number of select cancer cases that were probably caused by HPV in the U.S. per year from 2017 to 2021, by site

U.S. rate of new HPV-associated cancers in 2022, by cancer type
Rate of new HPV-associated cancers in the United States in 2022, by cancer type (per 100,000 people)

Percentage of select cancers that were caused by HPV in the U.S. 2017-2021, by gender
Percentage of HPV-related cancers that were probably caused by HPV in the U.S. per year from 2017 to 2021, by gender*

Number of cancer cases that were caused by HPV in the U.S. 2017-2021, by gender
Number of select cancer cases that were probably caused by HPV in the U.S. per year from 2017 to 2021, by gender*

U.S. rate of new HPV-associated cancers in 2022, by age
Rate of new HPV-associated cancers in the United States in 2022, by age (per 100,000 people)

U.S. rate of new HPV-associated cancers in 2022, by race and ethnicity
Rate of new HPV-associated cancers in the United States in 2022, by race and ethnicity (per 100,000 people)

U.S. rate of new HPV-associated cancers in 2022, by state
Rate of new HPV-associated cancers in the United States in 2022, by state (per 100,000 people)

Share of U.S. teenagers who had an HPV vaccination 2024, by gender
Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2024, by gender

HPV vaccine coverage among U.S. adolescents as of 2024, by age
Percentage of adolescents in the U.S. who had received an HPV vaccine as of 2024, by age*

HPV vaccine coverage among U.S. female adolescents as of 2024, by age
Percentage of female adolescents in the U.S. who had received an HPV vaccine as of 2024, by age*

HPV vaccine coverage among U.S. male adolescents as of 2024, by age
Percentage of male adolescents in the U.S. who had received an HPV vaccine as of 2024, by age*

Share of U.S. college students vaccinated against HPV as of fall 2025, by gender
Percentage of college students in the U.S. who had been vaccinated against Human Papillomavirus (HPV), as of fall 2025, by gender
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.